GPX® Embolic Device meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
Trial Reports 99% Successful Occlusion of Flow with 40 Investigators Delivering the New Embolic Through 20 Different Catheters SALT LAKE CITY, UT, UNITED STATES, July 14, 2026 /EINPresswire.com/ -- Fluidx Medical Technology, Inc. announced the …